Form SEC STAFF LETTER - SEC Staff Letter: REDACTED EXHIBIT
SEC Accession No. 9999999997-21-000657
Filing Date
2021-03-11
Accepted
2021-02-12 09:07:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf REDACTED EXHIBIT 199298
  Complete submission text file 9999999997-21-000657.txt   275528
Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SEC STAFF LETTER
SIC: 2836 Biological Products, (No Diagnostic Substances)